Elizabeth A Grimm

Elizabeth A Grimm

UNVERIFIED PROFILE

Are you Elizabeth A Grimm?   Register this Author

Register author
Elizabeth A Grimm

Elizabeth A Grimm

Publications by authors named "Elizabeth A Grimm"

Are you Elizabeth A Grimm?   Register this Author

93Publications

1727Reads

30Profile Views

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.

Clin Cancer Res 2019 Mar 11;25(5):1650-1663. Epub 2018 Dec 11.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397703PMC
March 2019

Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.

J Invest Dermatol 2019 Mar 25;139(3):728-731. Epub 2018 Oct 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.10.009DOI Listing
March 2019

High-Throughput Architecture for Discovering Combination Cancer Therapeutics.

JCO Clin Cancer Inform 2018 12;2:1-12

Matt Gianni, Geert Wenes, and Becca Bandstra, Cray Inc, Seattle, WA; Yong Qin, Anthony P. Conley, Vivek Subbiah, Suhendan Ekmekcioglu, Elizabeth A. Grimm, and Jason Roszik, The University of Texas MD Anderson Cancer Center, Houston, TX; and Raya Leibowitz-Amit, Tel Aviv University Sackler School of Medicine, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/CCI.17.00054
Publisher Site
http://dx.doi.org/10.1200/CCI.17.00054DOI Listing
December 2018

Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.

JCO Precis Oncol 2018 5;2018. Epub 2018 Jun 5.

Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P. Macedo, Fernando Carapeto, Meredith A McKean, John Van Arnam, Agda K. Eterovic, Shiraj Sen, Charuta R. Kale, Xiaoxing Yu, Cara L. Haymaker, Mark Routbort, Lauren E. Haydu, Chantale Bernatchez, Alexander J. Lazar, Elizabeth A. Grimm, David S. Hong, and Scott E. Woodman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Mariana P. Macedo, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080631PMC
http://dx.doi.org/10.1200/PO.18.00055DOI Listing
June 2018

Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy.

Front Oncol 2018 16;8:67. Epub 2018 Mar 16.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864849PMC
March 2018

A tool for discovering drug sensitivity and gene expression associations in cancer cells.

PLoS One 2017 28;12(4):e0176763. Epub 2017 Apr 28.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176763PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409143PMC
September 2017

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.

Front Immunol 2017 16;8:689. Epub 2017 Jun 16.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.00689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473350PMC
June 2017

Targeting iNOS to increase efficacy of immunotherapies.

Hum Vaccin Immunother 2017 05 25;13(5):1105-1108. Epub 2017 Jan 25.

a Department of Melanoma Medical Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21645515.2016.1276682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443387PMC
May 2017

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression.

Melanoma Res 2017 04;27(2):126-133

Departments of aMelanoma Medical Oncology bOrbital Oncology and Ophthalmic Plastic Surgery cPlastic Surgery and Biostatistics dPathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA eDepartment of Pathology, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000329DOI Listing
April 2017

Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.

Mol Cancer Ther 2016 10 25;15(10):2442-2454. Epub 2016 Jul 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079683PMC
http://dx.doi.org/10.1158/1535-7163.MCT-15-0963DOI Listing
October 2016

Uveal melanoma: From diagnosis to treatment and the science in between.

Cancer 2016 08 15;122(15):2299-312. Epub 2016 Mar 15.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567680PMC
August 2016

Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.

Pigment Cell Melanoma Res 2016 May 15;29(3):297-308. Epub 2016 Mar 15.

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12455DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840087PMC
May 2016

4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis.

Melanoma Res 2016 Apr;26(2):181-7

Departments of aEpidemiology bSurgical Oncology cPathology dDermatology eMelanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas fCancer Biology gDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948741PMC
April 2016

Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma.

Medicine (Baltimore) 2016 Mar;95(11):e3073

From the Departments of Melanoma Medical Oncology Research (JO, JAE, EAG); Biostatistics (WW, MMJ); and Surgical Oncology (JEG, CMW), University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000003073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839916PMC
March 2016

Dual Roles of RNF2 in Melanoma Progression.

Cancer Discov 2015 Dec 8;5(12):1314-27. Epub 2015 Oct 8.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. Institute for Health Transformation, The University of Texas System, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670809PMC
December 2015

Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.

J Invest Dermatol 2015 Nov 3;135(11):2775-2784. Epub 2015 Jun 3.

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X154186
Publisher Site
http://dx.doi.org/10.1038/jid.2015.204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640965PMC
November 2015

IL-10: Expanding the Immune Oncology Horizon.

Receptors Clin Investig 2015;2(4). Epub 2015 Nov 4.

ARMO BioSciences 575 Chesapeake Drive Redwood City, CA 94063.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675350PMC
November 2015

Inflammatory IL-1β-driven JNK activation in stage III melanoma.

Pigment Cell Melanoma Res 2015 Mar 12;28(2):236-9. Epub 2015 Jan 12.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pcmr.12348
Publisher Site
http://dx.doi.org/10.1111/pcmr.12348DOI Listing
March 2015

Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration.

PLoS One 2014 13;9(2):e83957. Epub 2014 Feb 13.

Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America ; Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083957PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923717PMC
October 2014

Characterization of the inflammatory microenvironment and identification of potential therapeutic targets in wilms tumors.

Transl Oncol 2014 Aug 23;7(4):484-92. Epub 2014 Jun 23.

Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate Program in Genes and Development and Graduate Program in Human Molecular Genetics, The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2014.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202801PMC
August 2014

Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2.

Cancer Res 2014 Feb 7;74(4):1067-78. Epub 2014 Jan 7.

Authors' Affiliations: Departments of Otolaryngology, Dermatology, Immunology, and Oncological Sciences; Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, The Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai; The Tisch Cancer Institute; Department of Genetics and Genomic Sciences, One Gustave L. Levy Place, New York, New York; and Departments of Melanoma Medical Oncology and Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960077PMC
February 2014

Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target.

Clin Cancer Res 2013 Oct 18;19(20):5557-63. Epub 2013 Jul 18.

Authors' Affiliations: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Departments of Otolaryngology, Immunology, Oncological Science, and Dermatology, Mount Sinai School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-12-1554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873873PMC
October 2013

Polymorphisms of nucleotide excision repair genes predict melanoma survival.

J Invest Dermatol 2013 Jul 14;133(7):1813-21. Epub 2013 Feb 14.

Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2012.498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660504PMC
July 2013

Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening.

Pigment Cell Melanoma Res 2013 Jan 6;26(1):97-112. Epub 2012 Nov 6.

Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919534PMC
January 2013

The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.

Int J Cancer 2012 Aug 23;131(4):891-901. Epub 2011 Oct 23.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269542PMC
August 2012

Ultraviolet radiation and the slug transcription factor induce proinflammatory and immunomodulatory mediator expression in melanocytes.

J Skin Cancer 2012 13;2012:410925. Epub 2012 Jun 13.

Department of Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX 78957, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jsc/2012/410925/
Publisher Site
http://dx.doi.org/10.1155/2012/410925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382223PMC
August 2012

Association of activated c-Met with NRAS-mutated human melanomas.

Int J Cancer 2012 Jul 11;131(2):E56-65. Epub 2012 Jan 11.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337366PMC
July 2012

Slug expression during melanoma progression.

Am J Pathol 2012 Jun 13;180(6):2479-89. Epub 2012 Apr 13.

Department of Molecular Carcinogenesis, Science Park, University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2012.02.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378849PMC
June 2012

IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.

Melanoma Res 2012 Feb;22(1):19-29

Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0b013e32834d2506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253989PMC
February 2012

Zyflamend mediates therapeutic induction of autophagy to apoptosis in melanoma cells.

Nutr Cancer 2011 11;63(6):940-9. Epub 2011 Jul 11.

Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2011.586488DOI Listing
December 2011

Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.

Mol Cancer Res 2011 Nov 27;9(11):1537-50. Epub 2011 Sep 27.

Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-11-0279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387749PMC
November 2011

Tumor suppressor gene-based nanotherapy: from test tube to the clinic.

J Drug Deliv 2011 24;2011:465845. Epub 2011 Jan 24.

Department of Thoracic and Cardiovascular Surgery, The University of Texas of MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/465845DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065904PMC
July 2011

IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.

Melanoma Res 2011 Feb;21(1):44-56

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0b013e3283382155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945428PMC
February 2011

Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.

Eur J Cancer 2011 Jan 23;47(1):107-15. Epub 2010 Jul 23.

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.06.129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987546PMC
January 2011

IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes.

Exp Dermatol 2010 Aug;19(8):714-22

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0625.2010.01077.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161412PMC
August 2010

Promotion of melanoma growth by the metabolic hormone leptin.

Oncol Rep 2010 Apr;23(4):901-7

Department of Experimental Therapeutics, Unit 362, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158136PMC
http://dx.doi.org/10.3892/or_00000713DOI Listing
April 2010

Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma.

J Invest Dermatol 2009 Jun;129(6):1483-8

The Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2008.374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741006PMC
June 2009

Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma.

J Urol 2009 Mar 16;181(3):1028-34; discussion 1034. Epub 2009 Jan 16.

Department of Experimental Therapeutics and Division of Quantitative Sciences (WW, MMJ), University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2008.11.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739625PMC
March 2009

NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma.

J Invest Dermatol 2009 Jan 31;129(1):148-54. Epub 2008 Jul 31.

Department of Experimental Therapeutics, The University of Texas, M.D Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022202X1534046
Publisher Site
http://dx.doi.org/10.1038/jid.2008.205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758038PMC
January 2009

Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.

Nitric Oxide 2008 Sep 22;19(2):133-7. Epub 2008 Apr 22.

Department of Experimental Therapeutics, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.niox.2008.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577016PMC
September 2008

Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24.

Cytokine 2008 Jul 3;43(1):34-44. Epub 2008 Jun 3.

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 362, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2008.04.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582834PMC
July 2008

WP760, a melanoma selective drug.

Cancer Chemother Pharmacol 2007 Oct 29;60(5):625-33. Epub 2006 Dec 29.

Department of Experimental Therapeutics, Unit 362, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-006-0404-5
Publisher Site
http://dx.doi.org/10.1007/s00280-006-0404-5DOI Listing
October 2007

Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.

Cancer 2007 Apr;109(8):1570-8

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22582DOI Listing
April 2007

Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.

J Invest Dermatol 2007 Feb 21;127(2):276-80. Epub 2006 Sep 21.

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jid.5700544DOI Listing
February 2007

Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.

Cancer Epidemiol Biomarkers Prev 2006 Dec;15(12):2526-32

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Unit 1365, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0672DOI Listing
December 2006

Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes.

J Interferon Cytokine Res 2006 Dec;26(12):877-86

Department of Experimental Therapeutics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jir.2006.26.877DOI Listing
December 2006

Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma.

Carcinogenesis 2006 Sep 18;27(9):1894-901. Epub 2006 Apr 18.

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgl042DOI Listing
September 2006

Challenges of chemosensitivity testing.

Clin Cancer Res 2006 Sep;12(18):5258-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1656DOI Listing
September 2006

Tumor iNOS predicts poor survival for stage III melanoma patients.

Int J Cancer 2006 Aug;119(4):861-6

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.21767
Publisher Site
http://dx.doi.org/10.1002/ijc.21767DOI Listing
August 2006

Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.

Pharmacogenet Genomics 2006 Apr;16(4):253-63

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.fpc.0000199501.54466.deDOI Listing
April 2006

Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells.

J Leukoc Biol 2005 Sep 6;78(3):745-52. Epub 2005 Jul 6.

Experimental Therapeutics, Box 362, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0205116DOI Listing
September 2005

NO news is not necessarily good news in cancer.

Curr Cancer Drug Targets 2005 Mar;5(2):103-15

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
March 2005

Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.

Breast Cancer Res 2004 4;6(4):R408-15. Epub 2004 Jun 4.

Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC468660PMC
November 2004

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.

Cancer 2004 Aug;101(3):596-603

Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20403DOI Listing
August 2004

Expression of thyrotropin-releasing hormone by human melanoma and nevi.

Clin Cancer Res 2004 Aug;10(16):5531-6

Department of Bioimmunotherapy, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-03-0368DOI Listing
August 2004

Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells.

Melanoma Res 2004 Jun;14(3):165-71

Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
June 2004

High prevalence of hypothyroidism among patients with cutaneous melanoma.

Oncol Rep 2003 Sep-Oct;10(5):1317-20

Department of Bioimmunotherapy, M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

View Article

Download full-text PDF

Source
April 2004

mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.

Cancer Biol Ther 2003 Jul-Aug;2(4 Suppl 1):S23-37

Departments of Pathology, Neurosurgery and Urology, Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons; New York, New York 1032, USA.

View Article

Download full-text PDF

Source
February 2004

Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines.

J Biol Chem 2004 Jan 23;279(1):288-98. Epub 2003 Oct 23.

University of Texas Graduate School of Biomedical Sciences and the Department of Bioimmunotherapy, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M310821200DOI Listing
January 2004

A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.

Mol Cancer Ther 2002 Oct;1(12):1009-17

Department of Bioimmunotherapy, Sections of Immunobiology and Drug Carriers, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
October 2002

Loss of MDA-7 expression with progression of melanoma.

J Clin Oncol 2002 Feb;20(4):1069-74

Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.4.1069DOI Listing
February 2002